| 1 |
Clemis V, Zaidi M, Fofana B. Genome-Editing Tools for Flax Genetic Improvement. The Flax Genome 2023. [DOI: 10.1007/978-3-031-16061-5_11] [Reference Citation Analysis]
|
| 2 |
Saber Sichani A, Ranjbar M, Baneshi M, Torabi Zadeh F, Fallahi J. A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing. Mol Biotechnol 2022. [DOI: 10.1007/s12033-022-00639-1] [Reference Citation Analysis]
|
| 3 |
Freen-van Heeren JJ. Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV. BioTech 2022;11:25. [DOI: 10.3390/biotech11030025] [Reference Citation Analysis]
|
| 4 |
Rudd H, Toborek M. Pitfalls of Antiretroviral Therapy: Current Status and Long-Term CNS Toxicity. Biomolecules 2022;12:894. [DOI: 10.3390/biom12070894] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Kavaliauskaitė J, Kazlauskaitė A, Lazutka JR, Mozolevskis G, Stirkė A. Pulsed Electric Fields Alter Expression of NF-κB Promoter-Controlled Gene. Int J Mol Sci 2021;23:451. [PMID: 35008875 DOI: 10.3390/ijms23010451] [Reference Citation Analysis]
|
| 6 |
Xun J, Zhang X, Guo S, Lu H, Chen J. Editing out HIV: application of gene editing technology to achieve functional cure. Retrovirology 2021;18:39. [PMID: 34922576 DOI: 10.1186/s12977-021-00581-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 7 |
Cao G, Xuan X, Zhang R, Hu J, Dong H. Gene Therapy for Cardiovascular Disease: Basic Research and Clinical Prospects. Front Cardiovasc Med 2021;8:760140. [PMID: 34805315 DOI: 10.3389/fcvm.2021.760140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
González Castro N, Bjelic J, Malhotra G, Huang C, Alsaffar SH. Comparison of the Feasibility, Efficiency, and Safety of Genome Editing Technologies. Int J Mol Sci 2021;22:10355. [PMID: 34638696 DOI: 10.3390/ijms221910355] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Anurogo D, Yuli Prasetyo Budi N, Thi Ngo MH, Huang YH, Pawitan JA. Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing. Int J Mol Sci 2021;22:6275. [PMID: 34200975 DOI: 10.3390/ijms22126275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 10 |
Rodgers T, Muzzio N, Watson C, Romero G. Stabilization of Poly (β-Amino Ester) Nanoparticles for the Efficient Intracellular Delivery of PiggyBac Transposon. Bioengineering (Basel) 2021;8:16. [PMID: 33498466 DOI: 10.3390/bioengineering8020016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Olson A, Basukala B, Lee S, Gagne M, Wong WW, Henderson AJ. Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9. Viruses 2020;12:E1154. [PMID: 33053801 DOI: 10.3390/v12101154] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 12 |
Pavlovic K, Tristán-Manzano M, Maldonado-Pérez N, Cortijo-Gutierrez M, Sánchez-Hernández S, Justicia-Lirio P, Carmona MD, Herrera C, Martin F, Benabdellah K. Using Gene Editing Approaches to Fine-Tune the Immune System. Front Immunol 2020;11:570672. [PMID: 33117361 DOI: 10.3389/fimmu.2020.570672] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
D'Souza MH, Patel TR. Biodefense Implications of New-World Hantaviruses. Front Bioeng Biotechnol 2020;8:925. [PMID: 32850756 DOI: 10.3389/fbioe.2020.00925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 14 |
Zheng N, Li L, Wang X. Molecular mechanisms, off-target activities, and clinical potentials of genome editing systems. Clin Transl Med 2020;10:412-26. [PMID: 32508055 DOI: 10.1002/ctm2.34] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 15 |
Dash PK, Kevadiya BD, Su H, Banoub MG, Gendelman HE. Pathways towards human immunodeficiency virus elimination. EBioMedicine 2020;53:102667. [PMID: 32114397 DOI: 10.1016/j.ebiom.2020.102667] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 16 |
Veenhuis RT, Clements JE, Gama L. HIV Eradication Strategies: Implications for the Central Nervous System. Curr HIV/AIDS Rep 2019;16:96-104. [PMID: 30734905 DOI: 10.1007/s11904-019-00428-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 17 |
Olson A, Basukala B, Wong WW, Henderson AJ. Targeting HIV-1 proviral transcription. Curr Opin Virol 2019;38:89-96. [PMID: 31473372 DOI: 10.1016/j.coviro.2019.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Das AT, Binda CS, Berkhout B. Elimination of infectious HIV DNA by CRISPR-Cas9. Curr Opin Virol 2019;38:81-8. [PMID: 31450074 DOI: 10.1016/j.coviro.2019.07.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 19 |
Peterson CW, Kiem HP. Cell and Gene Therapy for HIV Cure. Curr Top Microbiol Immunol 2018;417:211-48. [PMID: 29256135 DOI: 10.1007/82_2017_71] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 20 |
Darcis G, Binda CS, Klaver B, Herrera-Carrillo E, Berkhout B, Das AT. The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape. Viruses 2019;11:E255. [PMID: 30871200 DOI: 10.3390/v11030255] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 21 |
Lampi Y, Van Looveren D, Vranckx LS, Thiry I, Bornschein S, Debyser Z, Gijsbers R. Targeted editing of the PSIP1 gene encoding LEDGF/p75 protects cells against HIV infection. Sci Rep 2019;9:2389. [PMID: 30787394 DOI: 10.1038/s41598-019-38718-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 22 |
Delagreverie HM, Gerard L, Chaillon A, Roelens M, Djerroudi L, Salmona M, Larghero J, Galicier L, Simon F, Oksenhendler E, Moins-Teisserenc H, Delaugerre C. Reconstitution of HIV-1 reservoir following high-dose chemotherapy/autologous stem cell transplantation for lymphoma. AIDS 2019;33:247-57. [PMID: 30325771 DOI: 10.1097/QAD.0000000000002051] [Reference Citation Analysis]
|
| 23 |
Bacman SR, Moraes CT. Elimination of Mutant Mitochondrial DNA in Mitochondrial Myopathies Using Gene-Editing Enzymes. Muscle Gene Therapy 2019. [DOI: 10.1007/978-3-030-03095-7_34] [Reference Citation Analysis]
|
| 24 |
Pereira Cabral B, da Graça Derengowski Fonseca M, Batista Mota F. What is the future of cancer care? A technology foresight assessment of experts’ expectations. Economics of Innovation and New Technology 2018;28:635-52. [DOI: 10.1080/10438599.2018.1549788] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 25 |
Zhao Q, Cao L, Guan L, Bie L, Wang S, Xie B, Chen X, Shen X, Cao F. Immunotherapy for gastric cancer: dilemmas and prospect. Briefings in Functional Genomics 2019;18:107-12. [DOI: 10.1093/bfgp/ely019] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 26 |
Falkenhagen A, Joshi S. Genetic Strategies for HIV Treatment and Prevention. Mol Ther Nucleic Acids 2018;13:514-33. [PMID: 30388625 DOI: 10.1016/j.omtn.2018.09.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 27 |
Ho BX, Loh SJH, Chan WK, Soh BS. In Vivo Genome Editing as a Therapeutic Approach. Int J Mol Sci 2018;19:E2721. [PMID: 30213032 DOI: 10.3390/ijms19092721] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 28 |
Wang G, Zhao N, Berkhout B, Das AT. CRISPR-Cas based antiviral strategies against HIV-1. Virus Research 2018;244:321-32. [DOI: 10.1016/j.virusres.2017.07.020] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 29 |
Hotter D, Kirchhoff F. Interferons and beyond: Induction of antiretroviral restriction factors. J Leukoc Biol 2018;103:465-77. [PMID: 29345347 DOI: 10.1002/JLB.3MR0717-307R] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 30 |
Niyonzima N, Lambert AR, Werther R, De Silva Feelixge H, Roychoudhury P, Greninger AL, Stone D, Stoddard BL, Jerome KR. Tuning DNA binding affinity and cleavage specificity of an engineered gene-targeting nuclease via surface display, flow cytometry and cellular analyses. Protein Eng Des Sel 2017;30:503-22. [PMID: 28873986 DOI: 10.1093/protein/gzx037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 31 |
Soppe JA, Lebbink RJ. Antiviral Goes Viral: Harnessing CRISPR/Cas9 to Combat Viruses in Humans. Trends in Microbiology 2017;25:833-50. [DOI: 10.1016/j.tim.2017.04.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 32 |
Xu W, Li H, Wang Q, Hua C, Zhang H, Li W, Jiang S, Lu L. Advancements in Developing Strategies for Sterilizing and Functional HIV Cures. Biomed Res Int 2017;2017:6096134. [PMID: 28529952 DOI: 10.1155/2017/6096134] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 33 |
Delhove JMKM, Qasim W. Genome-Edited T Cell Therapies. Curr Stem Cell Rep 2017;3:124-36. [PMID: 28596938 DOI: 10.1007/s40778-017-0077-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 34 |
Khalili K, White MK, Jacobson JM. Novel AIDS therapies based on gene editing. Cell Mol Life Sci 2017;74:2439-50. [PMID: 28210784 DOI: 10.1007/s00018-017-2479-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 35 |
Hardee CL, Arévalo-Soliz LM, Hornstein BD, Zechiedrich L. Advances in Non-Viral DNA Vectors for Gene Therapy. Genes (Basel) 2017;8:E65. [PMID: 28208635 DOI: 10.3390/genes8020065] [Cited by in Crossref: 221] [Cited by in F6Publishing: 229] [Article Influence: 36.8] [Reference Citation Analysis]
|
| 36 |
Chen KY, Knoepfler PS. To CRISPR and beyond: the evolution of genome editing in stem cells. Regen Med 2016;11:801-16. [PMID: 27905217 DOI: 10.2217/rme-2016-0107] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 37 |
Perez-Pinera P, Chen ZY. Biomedical applications of gene editing. Hum Genet 2016;135:967-9. [PMID: 27535845 DOI: 10.1007/s00439-016-1723-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 38 |
Stone D, Niyonzima N, Jerome KR. Genome editing and the next generation of antiviral therapy. Hum Genet 2016;135:1071-82. [PMID: 27272125 DOI: 10.1007/s00439-016-1686-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
|
